Shingrix Prices, Coupons, Copay Cards & Patient Assistance
Shingrix (zoster vaccine, recombinant) is a member of the viral vaccines drug class and is commonly used for Herpes Zoster - Prophylaxis.
Shingrix prices
Intramuscular Powder For Injection
adjuvanted Shingrix intramuscular powder for injection from $240.06 for 1 powder for injection
| Quantity | Per unit | Price |
|---|---|---|
| 1 | $240.06 | $240.06 |
| 10 | $231.06 | $2,310.59 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Shingrix Coupons, Copay Cards and Rebates
Shingrix offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
No manufacturer promotions could be found for this medication.
Patient Assistance & Copay Programs for Shingrix
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: GSK Patient Assistance Vaccine Program
Eligibility requirements:- Must be uninsured
- At or below 300% of FPL
- Not required
- The patient must also be residing in the US or Puerto Rico
- As a result of the Inflation Reduction Act (IRA) changes, Medicare Part D patients with vaccine needs will receive their product through the IRA. Please contact the program for more information. FOR HEALTHCARE PROFESSIONALS: GSK Patient Assistance Program (GSK PAP) is no longer able to offer single dose vials for PAP replenishment. A site must accumulate a total of 10 doses within 12 months in order to be eligible for replenishment through the program. Doses approved for all practicing physicians at a unique site address will count towards the accumulation. Furthermore, the total amount of replenishment product received through the GSK PAP will be capped at 200 doses per product per year (20 shipments of 10 vaccines) per unique site.
- Shingrix (zoster vaccine recombinant) Injection
More information please phone: 866-728-4368 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Zostavax
Zostavax is used to prevent herpes zoster virus (shingles). Includes Zostavax side effects ...
Abrysvo
Abrysvo is a vaccine used to prevent respiratory syncytial virus (RSV) lower respiratory tract ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
ACAM2000
ACAM2000 vaccine may be used to prevent smallpox and mpox disease in people of any age at high risk ...
Afluria
Afluria is a vaccine used to prevent infection caused by influenza virus. Learn about side effects ...
Afluria Preservative-Free Pediatric Quadrivalent
Afluria Preservative-Free Pediatric Quadrivalent is used for influenza prophylaxis
Afluria Preservative-Free Quadrivalent
Afluria Preservative-Free Quadrivalent is used for influenza prophylaxis
Afluria Quadrivalent
Afluria Quadrivalent is used for influenza prophylaxis
Arexvy
Arexvy is a vaccine used to prevent respiratory syncytial virus (RSV) lower respiratory tract ...
More about Shingrix (zoster vaccine, recombinant)
- Check interactions
- Compare alternatives
- Reviews (625)
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: viral vaccines
- En español